New York Passes Legislation To Manufacture Own Generic Drugs
The Legislation Also Covers Pay-For-Delay Agreements, Wholesale Drug Importation, And More
If signed into law, New York will follow in California’s footsteps and become the second state to seek its own drug manufacturing opportunities to improve accessibility and affordability.
You may also be interested in...
The America First Policy Institute has blamed patent abuse for drug unaffordability, poking holes in governmental institutions and their current systems.
The House Ways and Means Committee may take more of a kitchen sink approach to addressing drug shortages than other congressional committees that have been primarily focused on paying for quality. Hearing witnesses said Congress must follow through on funding incentives for US onshoring.
FDA Commissioner is ‘pretty excited’ about obtaining high quality evidence in the postmarket space, noting agency's collaboration with NIH. He cites need to address the low cost of generic drugs as a factor in drug shortages.